Stealthy early-stage NVision Medical raises $6.5m

Stealthy NVision Medical raised $6.5 million in a new round of equity financing to support its ovarian cancer diagnostic device, according to an SEC filing.

NVision is an early-stage medical device company focused on women’s health, specifically creating in-office diagnostics for ovarian cancer and fallopian tube blockages, according to a 2014 interview with MedCity News.

The company was incorporated in 2009, is based in San Francisco, Calif., and is run by founder and CEO Surbhi Sarna.

Money in the round came from 17 unnamed sources, and the company is still looking for another $5.5 million before closing, according to an SEC filing.

NVision has not yet stated how they plan to use funds from the round.

The post Stealthy early-stage NVision Medical raises $6.5m appeared first on MassDevice.

from MassDevice http://ift.tt/29Zac6Q